Not Yet RecruitingNot Applicable

Outcome of Transcatheter Closure of Patent Ductus Arteriosus in Pediatric Cardiology Unit in 3 Years Duration

90 participantsStarted 2024-10-25

Plain-language summary

Transcatheter Closure of Patent Ductus Arteriosus to evaluate the outcome of percutaneous transcatheter closure of patent ductus arteriosus in children

Who can participate

Age range6 Months – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children with Patent Ductus Arteriosus confirmed by echocardiography * aged from 6 months to 16 years underwent percutaneous transcatheter PDA closure at Pediatric Cardiology Unit. Exclusion Criteria: * Children with PDA younger than 6 months or older than 16 years and that are not candidate for transcatheter closure .

What they're measuring

outcome of trancathter PDA closure

Timeframe: 3 years

Trial details

NCT IDNCT06634407

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-01

Contact for this trial

Bassem Eldaba Fares bassem fares

+201220851469 basam.13298661@med.aun.edu.eg

View on ClinicalTrials.gov More Patent Ductus Arteriosus (PDA) trials